COVID-19 Advice and links

We know you are all doing everything you can to keep yourselves, your families and your patients safe from Covid-19. 

The following documents have been prepared by the clinical expert group on lung cancer and include a modified National Optimal Lung Cancer Pathway and guidance on bronchoscopy services during COVID-19

Bronchoscopy services during COVID-19

Updated lung cancer pathway during COVID-19

Recovery following COVID-19

Recovering from COIVD-19 - a practical guide for clinicians and commissioners

NHS guidance on After care needs of inpatients recovering from COVID-19

Other credible information

We will try to signpost you to the latest important information and guidance including:

Maps

Repositories of Covid-19 studies

 Managing Clinical trials during Coronavirus Pandemic. The Medicines and Healthcare Products Regulatory Agency (MHRA)  is adopting as flexible and pragmatic an approach as possible with regard to regulatory requirements for clinical trials during this time. They have recognised that clinical trial resource may be absent or redeployed from research activities and regulatory affairs towards front-line care. Their first priority is the safety of trial participants. This guidance will be updated as the situation changes over time and contains information on pausing clinical trials.

World Health Organisation Information

WHO statement and information

Patients

Shared documents on palliative care and Covid-19

Join Lung Cancer Nursing UK

Be a member of a dynamic and cohesive forum of lung cancer nurse specialists (LCNS) working throughout the UK. Membership costs just £30 per year and is open to any specialist nurse who spends more than 50% of their working week or clinical activities in caring for patients with lung cancer.

Join Now

COVID-19 Coronovirus

How to look after yourself during the Covid-19 Coronavirus

Find out more